Browse 14081 Federal Education Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Education grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| January 7th, 2021 |
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) |
National Institutes of Health |
| September 28th, 2018 |
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed) |
National Institutes of Health |
| September 28th, 2018 |
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed) |
National Institutes of Health |
| February 24th, 2020 |
National Cooperative Drug/Device Discovery/Development Groups (U01 Clinical Trial Optional) |
National Institutes of Health |
| March 29th, 2019 |
Research To Address Sleep Disorders in the Context of Medical Rehabilitation (R01 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2020 |
NCI Small Grants Program for Cancer Research (NCI Omnibus R03 Clinical Trial Optional) |
National Institutes of Health |
| September 28th, 2018 |
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 - Clinical Trial Not Allowed) |
National Institutes of Health |
| September 28th, 2018 |
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 - Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2021 |
NCI Transition Career Development Award to Promote Diversity (K22 - No Clinical Trials) |
National Institutes of Health |
| January 7th, 2021 |
NCI Mentored Research Scientist Development Award to Promote Diversity (K01) |
National Institutes of Health |
| September 7th, 2019 |
Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R21/R33 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2021 |
NCI Mentored Research Scientist Development Award to Promote Diversity (K01) |
National Institutes of Health |
| September 7th, 2019 |
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2019 |
Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R33 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2018 |
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Optional) |
National Institutes of Health |
| March 22nd, 2019 |
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2019 |
Integrative Research on Polysubstance Abuse and Addiction (R21/R33 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2019 |
Behavioral Science Track Award for Rapid Transition (B/Start)(R03 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2018 |
Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional) |
National Institutes of Health |
| January 9th, 2020 |
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54) |
National Institutes of Health |
|
| See Grant Text |
Education Center for Children of Yellowstone National Park |
National Park Service |
| May 7th, 2018 |
Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2018 |
Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R21 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2018 |
Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R03 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2018 |
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Abuse (R34 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2018 |
International Research Collaboration on Drug Abuse and Addiction Research (R21 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2019 |
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2018 |
AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2018 |
Development and Testing of Novel Interventions to Improve HIV Prevention, Care, and Program Implementation (R34 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2018 |
Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2018 |
International Research Collaboration on Drug Abuse and Addiction Research (R03 Clinical Trial Optional) |
National Institutes of Health |
| February 21st, 2018 |
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) |
National Institutes of Health |
| May 7th, 2019 |
Population Health Interventions: Integrating Individual and Group Level Evidence (R21)- Clinical Trials Not Allowed |
National Institutes of Health |
| January 7th, 2019 |
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) |
National Institutes of Health |
| November 8th, 2018 |
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2020 |
Reducing Health Disparities Among Minority and Underserved Children (R21 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2020 |
Chronic Condition Self-Management in Children and Adolescents (R21 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2020 |
Reducing Health Disparities Among Minority and Underserved Children (R01 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2020 |
Chronic Condition Self-Management in Children and Adolescents (R01 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2020 |
Promoting Caregiver Health Using Self-Management (R01 Clinical Trial Optional) |
National Institutes of Health |
